The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume their roles in April 2024 following ACC.24 in Atlanta, Ga.
News | ACC
ACC Announces New 2024 Officers, Trustees

July 20, 2023 โ€” The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume ...

Home July 20, 2023
Home
Bicรชtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients
News | Stroke
First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment

July 20, 2023 โ€” The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...

Home July 20, 2023
Home
A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical protocol for cardiovascular computed tomography (CCT) to guide intervention in the right ventricular outflow tract (RVOT) in patients with congenital heart disease (CHD).
News | Computed Tomography (CT)
Optimal CHD Patient Care Requires Interventional, Surgical Collaboration

July 20, 2023 โ€” A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical ...

Home July 20, 2023
Home
Feature | SCCT | Christine Book
Society of Cardiovascular Computed Tomography (SCCT) Sets Stage for 18th Annual Scientific Meeting, SCCT 2023

July 20, 2023 โ€” The Society of Cardiovascular Computed Tomography (SCCT) is preparing for its 18th Annual Scientific ...

Home July 20, 2023
Home
The future is quite promising for TAHs, but it will be a decade or more before they may become a comparable treatment to heart transplantation
Feature | Artificial Heart | By Francisco Arabia, MD, MBA
Next-Generation Total Artificial Hearts Offer New Hope for Heart Failure Patients

The U.S. organ donation system has long been under scrutiny, with questions about fairness in organ allocation and ...

Home July 20, 2023
Home
The U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers recommending that health care providers, laboratory personnel, and facilities stop using the Quidel Triage Cardiac Panel, manufactured by Quidel Cardiovascular Inc. (QuidelOrtho), and use an alternative method, or an alternate local testing site if available.
News | Heart Failure
FDA Issues Letter to Healthcare Providers on Using Alternative Testing Method for Quidel Triage Cardiac Pane

July 19, 2023 โ€” The U.S. Food and Drug Administration (FDA) is recommending health care providers, laboratory personnel ...

Home July 19, 2023
Home
The proposed approach outperforms other neural network architectures by leveraging rich geometric information to segment brain stroke lesion images
News | Stroke
New Geometric Deep Learning Model for Detecting Stroke Lesions

July 19, 2023 โ€” Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the ...

Home July 19, 2023
Home
EU Physicians have successfully treated the first patients using the combined benefits of Abbottโ€™s Ensite X Mapping System and Stereotaxisโ€™ Robotic Magnetic Navigation System
News | Robotic Systems
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients

July 19, 2023 โ€” Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home July 19, 2023
Home
Medtronic is recalling all ICDs and CRT-Ds, manufactured after 2017, with a glassed feedthrough as they may deliver low or no energy output when needed for high voltage therapy.
News | Implantable Cardioverter Defibrillator (ICD)
Medtronic Recalls ICDs and CRT-Ds for Risk of Low or No Energy Output During High Voltage Therapy

July 18, 2023 โ€” The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
Quidel Cardiovascular is recalling its Quidel Triage Cardiac Panels for risk of false negative troponin results that could cause delayed diagnosis or missed myocardial infarction
News | Heart Failure
Quidel Cardiovascular Inc. Recalls Quidel Triage Cardiac Panels for Risk of False Negative Troponin Results

July 18, 2023 โ€” The U.S. Food and Drug Administration (FDA) has issued a Class I recall on Quidel Cardiovascular is ...

Home July 18, 2023
Home
A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention
News | Artificial Intelligence
AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 โ€” The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

Home July 18, 2023
Home
Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases
News | Cardiovascular Business
Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases

July 14, 2023 โ€” Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire ...

Home July 14, 2023
Home
No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB
News | Drug-Eluting Balloons
BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 โ€” BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

Home July 14, 2023
Home
Illustration for the deployment and shaping process of the occluder.
News | Structural Heart Occluders
Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 โ€” In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

Home July 14, 2023
Home
Anne Snowdon, RN, PhD, FAAN
Feature | Information Technology | By Melinda Taschetta-Millane
One on One ... With Anne Snowdon, RN, PhD, FAAN

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this ...

Home July 14, 2023
Home
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now